Fiagon: Intersect ENT Closes Acquisition of Fiagon AG Medical Technologies

Intersect ENT, Inc. (Nasdaq: XENT), a company transforming care for patients with ear, nose and throat ("ENT") conditions, today announced it closed the previously announced transaction to acquire Fiagon AG Medical Technologies , a leader in electromagnetic surgical navigation solutions, for €60 million in cash. Under the previously disclosed terms of the agreement, as announced on September 15, 20